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Enzymes are proteins evolved by the cells of living organisms. Their specific function is to catalyse 
chemical reactions. Enzymes increase the rate at which reactions approach equilibrium. Enzymes have 
found wide and diverse applications in different disciplines and fields of human endeavours. Enzymes 
play critical role in the metabolic activities of all living organisms, whether humans, animals, plants or 
microorganisms and are widely applied in agriculture, biochemistry, biotechnology, chemistry, 
genetics, industries, human and veterinary medicine, pharmacy, research, etc. The different 
applications of enzymes abound in the literature. The aim of this review is to discuss the diverse 
applications of enzymes for the purpose of teaching, education and research.  
 





Enzymes are biological catalysts that increase the rate of 
chemical reactions taking place within living cells without 
themselves undergoing any overall change (Palmer, 
2001). Enzymes play vital roles in biological systems by 
acting as catalysts. A catalyst is necessary in such sys-
tems because, at the temperature and pH of the human 
and animal body, reactions would not occur at a rate 
sufficient to support rapid muscular activity, nerve 
impulse generation and all the other processes required 
to support life (Devlin, 1986). The investigation and inter-
pretation of changes in serum enzymes in diseases is 
one of the most rapidly expanding fields in clinical bio-
chemistry (Chatterjea and Shinde, 2002). 
Enzymes are unchanged by their action on their sub-
strates; they remain as they are and active until 
denatured by heat or other factors or until the substrate is 
exhausted. Depending on the process, enzymes may be 
removed from the final product, or denatured and left in, 
or may even be potentially active. How they are labelled 
in final product formulations should be dependent on the 
specific outcome for the product in question. 
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rent fields of research or areas of life. In human and 
veterinary medicine, the assay of plasma enzymes can 
be very useful in helping to confirm the diagnosis of 
diseases in humans and animals. In recombinant DNA 
technology (sometimes called genetic engineering), 
varieties of enzymes are used, e.g. restriction endo-
nucleases (from bacteria) and DNA ligases (from bacteria 
or bacteriophages), to insert extra genes into cells with 
the help of vehicles termed vectors. The diagnosis of an 
inborn error of metabolism can be established by demon-
strating the reduced activity of a particular enzyme in a 
tissue, or by revealing a gene abnormality by recom-
binant DNA technology (Palmer, 2001). Enzymes are 
also applied in the management and treatment of some 
diseases. Enzymes are used as reagents in clinical 
biochemistry and in the industry. Enzyme assay is very 
important in the food and drink industries in monitoring 
the processing and storage of foods and drinks and as a 
means of detecting microbial contamination. All these 
applications will be discussed in details. 
Due to the importance of enzymes and its wide applica-
tions in biochemistry, biotechnology, chemistry, genetics, 
industries, human and veterinary medicine etc., this 
review is an attempt to gather together the different uses 
and applications of enzymes for the purposes of teaching 





BIOMEDICAL IMPORTANCE OF ENZYMES 
 
Enzymes are biologic polymers that catalyze the multiple 
dynamic processes which makes life processes possible. 
Enzymes play central role in health and disease because 
they are determinants of the rates at which physiologic 
events take place. The breakdown of foods to supply 
energy and chemical building blocks, the assembly of 
these building blocks into proteins, membranes and the 
DNA that encodes genetic information and the harness-
sing of energy to produce cell movement are all made 
possible by the carefully coordinated actions of enzymes 
(Murray et al., 2000).   
While in health, all biochemical and physiological pro-
cesses occur in an ordered, regulated manner and home-
ostasis is maintained, homeostasis can be profoundly 
disturbed in pathologic states. For example, the severe 
tissue injury that catalyses liver cirrhosis can profoundly 
impair the ability of cells to form the enzymes which 
catalyze a key metabolic process such as urea synthesis. 
The resultant inability to convert toxic ammonia to non 
toxic urea is then followed by ammonia intoxication and 
ultimately hepatic coma (Murray et al., 2000). A series of 
rare but frequently debilitating and often fatal genetic 
diseases are additional examples of the drastic phy-
siologic consequences that can follow impairment of the 
activity of a single enzyme. 
Following severe tissue injury (e.g. cardiac or lung 
infarct, crushed limb, liver damage or trauma to the liver) 
or uncontrolled cell growth (e.g. prostatic carcinoma), 
enzymes that may be unique to specific tissues are 
released into the blood. Measurement of these intra-
cellular enzymes in blood serum therefore provides 
medical and veterinary doctors with invaluable infor-
mation on the diagnosis and prognosis of diseases in the 
human and animal body/system.     
 
 
Enzyme Commission (E.C.)  
 
This is a special commission of the International Union of 
Biochemistry (IUB) that made recommendations for the 
classification and naming of enzymes and for the 
definitions of the mathematical constants used in enzy-
mology. The recommendations were first published in 
1964 and were published in revised form in 1972, 1978 
and 1984 (Stenesh, 1989). 
 
 
Enzyme classification  
 
This is the systematic arrangement and the naming of 
enzymes that is based on the 1972 recommendations of 
the Enzyme Commission of the International Union of 
Biochemistry (Stenesh, 1989). Reactions and the 
enzymes that catalyze them form 6 classes, each having 
4-13 subclasses. The enzyme name has 2 parts. The first  




names the substrate or substrates. The second, ending 
in-ase, indicates the type of reaction catalysed (Murray et 
al., 2000). Each enzyme is denoted by a number 
composed of four figures. The first figure denotes one of 
the six main divisions: oxidoreductases, transferases, 
hydrolases, lyases, isomerases and ligases. The second 
figure denotes the subclass and the third figure denotes 
the sub-subclass. The last figure denotes the serial 
number of the enzyme in its sub-subclass. The enzyme 
number is preceded by the abbreviation E.C. (Stenesh, 
1989). For example, E.C.2.7.1.1 denotes class 2 (a 
transferase), subclass 7 (transfer of phosphate), sub-
subclass 1 (an alcohol is the phosphate acceptor). The 
final digit denotes hexokinase, or ATP: D-hexose 6 -
phos-photransferase, an enzyme catalyzing phosphate 
transfer from ATP to the hydroxyl group on carbon 6 of 
glucose (Murray et al., 2000). There are 6 classes of 
enzymes. They are: 
 
(i) Oxidoreductases: These enzymes are involved in 
oxidations and reductions of their substrates e.g. alcohol 
dehydrogenase, lactate dehydrogenase, xanthine oxi-
dase, glutathione reductase, glucose-6-phosphate dehy-
drogenase. 
(ii) Transferases: These enzymes catalyze the transfer of 
a particular group from one substrate to another e.g. 
aspartate amino transferase (AST), alanine aminotrans-
ferase (ALT), hexokinase, phosphoglucomutase, hexose-
1-phosphate uridyltransferase, ornithine carbamoyl 
transferase etc.      
(iii) Hydrolases: These enzymes bring about hydrolysis 
e.g. glucose- 6 -phosphatase, pepsin, trypsin, esterases, 
glycoside hydrolases etc. 
(iv) Lyases: These are enzymes that facilitate the remo-
val of small molecule from a large substrate e.g. 
fumarase, argino succinase, histidine decarboxylase. 
(v) Isomerases: These enzymes are involved in isomeri-
zation of substrate e.g. UDP-glucose, epimerase, retinal 
isomerase, racemases, triose phosphate isomerase. 
(vi) Ligases: These enzymes are involved in joining 
together 2 substrates e.g. alanyl-t-RNA synthetase, gluta-
mine synthetase, DNA ligases (Chatterjea and Shinde, 





Specificity is an important characteristic of enzymes. The 
3 different types of enzyme specificity/specificities are: 
 
(i) Stereochemical specificity. 
(ii) Reaction specificity. 
(iii) Substrate specificity, which can be absolute or rela-
tive substrate specificity (Chatterjea and Shinde, 2002). 
 
 
Enzyme kinetics  
 
This is the kinetics of  enzyme-catalyzed  reactions. It  in- 




cludes derivations of rate equations and graphical analy-
sis of experimental data for all types of enzyme reactions 
such as single or multiple substrate reactions, uninhibited 
or inhibited reactions, equilibrium or steady-state systems 





This is an enzyme that is physically confined while it 
carries out its catalytic function. This may occur naturally, 
as in the case of particulate enzymes, or it may be pro-
duced artificially by chemical or by physical methods 
(Stenesh, 1989). In the chemical methods, the enzyme is 
linked covalently to a support. These methods include 
attachment of the enzyme to a water-insoluble support, 
incorporation of the enzyme into a growing polymer 
chain, or cross linking of the enzyme with a multi-
functional low molecular weight reagent. In the physical 
methods, the enzyme is not linked covalently to a 
support. These methods include adsorption of the 
enzyme to a water-insoluble matrix, entrapment of the 
enzyme within either a water-insoluble gel or a micro-
capsule, or containment of the enzyme within special 
devices equipped with semipermeable membrane 
(Stenesh, 1989). Enzyme immobilization technique has 2 
advantages:  
 
(i) Expensive enzymes can be recovered and used again.  
(ii) The enzyme can also be used in a variety of con-




COMMERCIAL APPLICATIONS OF IMMOBILIZED 
ENZYMES 
 
Immobilised enzymes are mainly used in the production 
of high fructose syrups (also known as HFCS or iso-
glucose). Other commercial uses include production of 
semi-synthetic penicillins, the hydrolysis of starch using 
amyloglucosidase and the resolution of DL-mixtures of 
amino acids (Coombs, 1992). Immobilized enzymes also 
have applications in the medical sciences.  
 
 
Enzymes and coenzymes 
 
Many enzymes require a coenzyme which functions as 
group transfer reagents. Many enzymes that catalyze 
group transfer and other reactions require, in addition to 
their substrate, a second organic molecule known as a 
coenzyme, without which they are inactive. Coenzymes 
expand the repertoire of the catalytic capabilities of an 
enzyme far beyond those offered by the functional groups 





enzyme. Coenzymes that are tightly associated with an 
enzyme through either covalent bonding or non covalent 
forces are often referred to as prosthetic groups (Murray 
et al., 2000). 
Coenzymes that are freely diffusible generally serve as 
continually recycled carriers of hydrogen, flavin adenine 
dinucleotide (reduced) (FADH), hydride nicotinamide 
adenine dinucleotide (reduced) (NADH) and nicotinamide 
adenine dinucleotide phosphate (reduced) (NADPH), or 
chemical units such as acyl groups (coenzyme A) or 
methyl groups (folates), shuttling them between their 
points of generation and consumption. These latter co-
enzymes can thus be considered as second substrates 
(Murray et al., 2000). 
Enzymes that require coenzymes include those which 
catalyze oxidoreductions, group transfer and isomeri-
zation reactions and reactions that form covalent bonds 
(IUB classes 1, 2, 5 and 6). Lytic reactions, including the 
hydrolytic reactions catalyzed by the digestive enzymes, 
do not require coenzymes. 
 
 
Classification of coenzymes  
 
Coenzymes can be classified according to the group 
whose transfer they facilitate. Based on the above 
concept, coenzymes may be classified as follows: 
 
(i) Coenzymes involved in transfer of groups other than 
hydrogen: Biotin, CoA-SH, cobamide (B12) coenzymes, 
folate coenzymes, pyridoxal phosphate, lipoic acid, sugar 
phosphates, thiamine pyrophosphate. 
(ii) Coenzymes involved in transfer of hydrogen. 
Nicotinamide adenine dinucleotide (oxidized) (NAD+), 
Nicotinamide adenine dinucleotide phosphate (oxidized) 
(NADP+). 
Flavin mononucleotide (FMN), Flavin adenine dinucle-




METHODOLOGY OF ENZYME PRODUCTION 
 
Enzymes are produced by cellular anabolism, the natu-
rally occurring biological process of making more com-
plex molecules from simpler ones. Source organisms 
include bacteria, fungi, higher plants and animals (White 
and White, 1997). Enzymes may be extracted from a 
given source organism by a number of different methods 
(Nielsen et al., 1991). Most of the organisms that produce 
commercial enzymes are fungi. These organisms are 
molds Rhizopus oryzae, Aspergillus niger, Rhizomucor 
meihei, blights such as Endothia parasitica and yeasts 
such as Saccharomyces spp. and Candida spp. 
A considerable amount of research has been con-
ducted on genetically modifying fungi or other organisms 





Many of the prospective donor organisms are reported 
to be pathogenic and are being screened for genetic 
sequences to be inserted into non-pathogenic hosts 
(Surgey et al., 1996). Classical methods of hybrid-
dization can also be used to improve enzyme-producing 





Enzyme preparations may consist of whole cells, parts of 
cells or cell-free extracts from the source used. Enzymes 
may be in liquid, semi-liquid or dry form. Enzymes in 
general are readily soluble in water. They are practically 
insoluble in alcohol, in chloroform and in ether. The 
colour of preparations may vary from virtually colourless 
to dark brown. Individual preparations are generally cha-
racterized by functionality and activity rather than the 
properties of the product (NAS, 1981). 
 
 
APPLICATIONS OF ENZYMES 
 
Enzymes have a wide variety of uses (ETA, 1999). They 
are used in the industries (food and drinks, pharma-
ceutical etc), they are used for research purposes, 
medical applications, commercial applications etc. 
 
 
Enzymes with biochemical applications 
 
Many enzymes are used in biochemical systems. Some 
of these are:  
 
a) aa-tRNA synthetase: It is used for charging a specific 
tRNA molecule with the appropriate amino acid. 
b) Adenylate cyclase: It produces cyclic Adenosine 
monophosphate (cAMP). 
c) Aspartokinase: This enzyme catalyses the initial step 
in the pathway for the biosynthesis of several amino 
acids. It’s a key regulatory step.  
d) ß-galactosidase: This enzyme splits lactose to the 
constituent monosaccharides glucose and galactose. It is 
the first step in lactose fermentation. 
e) ß-lactamase: This enzyme hydrolyses the ß-lactam 
bond in the nucleus of penicillins and cephalosporins. It is 
responsible for penicillin resistance.  
f) Chloramphenicol acetyltransferase (CAT): This enzyme 
causes chloramphenicol resistance, by inactivating the 
antibiotic and is used as a selective marker and as a 
reporter gene. 
g) Glutamate dehydrogenase: It is important in ammonia 
assimilation. 
h) Luciferase: This enzyme catalyses a light-emitting 
reaction. It is used as a reporter.  
 
i) Resolvase: It catalyses  site-specific  recombination  to  




resolve the co-integrate intermediate in transposition into 
two separate molecules. 
 
 
Enzymes with biotechnological applications 
 
There are many enzymes employed in biotechnological 
operations. These include: 
 
1) Alkaline phosphatase: In gene cloning, this enzyme is 
used to remove phosphate groups from the 5I end of 
DNA molecules and also used as a reporter gene for 
identification of secretion signals.  
2) Exonuclease: This is an enzyme that removes 
nucleotides from the ends of DNA fragments. A 5I----3I 
exonuclease removes nucleotides from the  5I end, while 
a 3I----5I exonuclease removes nucleotides from the 3I 
end.  
3) DNA polymerase 1: It is primarily known as a ‘repair’ 
polymerase, which fills in single-stranded gaps. It is also 
involved in repair of the gaps formed on the lagging 
strand during replication. It also possesses both 5I --- 3I 
and 3I --- 5I exonuclease activity.  
4) Klenow fragment of E. coli DNA polymerase 1: This 
enzyme is used for sequencing DNA using the Sanger 
Dideoxy System, filling the 3 recessed termini of 
restriction enzyme treated DNA and also used for 
labeling the termini of DNA fragments (Daini, 2000). The 
enzyme is also used for second strand cDNA synthesis in 
the cDNA procedures. ‘Klenow fragment’ is a proteolytic 
cleavage of DNA polymerase I. It leaves a fragment that 
is devoid of 5I---3I exonuclease activity.  
5) DNA polymerase III: This is the main ‘replication’ 
polymerase. 
6) Helicase: It unwinds DNA, for example in conjugal 
plasmid transfer.  
7) T4 DNA polymerase: This enzyme is used in the 
labeling of DNA fragments for use as hybridization 
probes. 
8) Terminal deoxynucleotidyl transferase: This enzyme is 
isolated from calf thymus and catalyses the addition of 
dNTP to the 3I-OH of DNA molecules. One of the primary 
uses of terminal transferase is the tailing of vectors and 
cDNA with complementary bases, thus permitting the 
cloning of the cDNA fragments (Daini, 2000). It can also 
be used for labeling of 3I ends of DNA fragments.  
9) T4 Polynucleotide kinase: This enzyme is isolated from 
T4 infected E. coli and catalyzes the transfer of  
phosphate of ATP to a 5I-OH end in DNA or RNA. It is 
also used for the labeling of 5I termini of DNA for Maxam 
and Gilbert DNA sequencing and the phosphorylation of 
DNA lacking 5I-P termini. 
10) Reverse transcriptase: This is an enzyme coded for 
by avian myeloblastosis virus. It catalyses the synthesis 
of cDNA from an RNA template. It can also be used for 
the labelling of termini of DNA with extended 5I ends. 
11) Restriction endonucleases:  Restriction  endonuclea- 




ses are enzymes that cut DNA molecules at specific 
positions. It recognizes ‘foreign’ (unmodified) DNA at a 
specific site, and degrades it by internal cleavage. Most 
commonly used are the type II restriction enzymes, which 
cut within the recognition site. Some examples are EcoRI 
from E. coli, HindIII from Haemophilus influenzae, BamHI 
from Bacillus amyloliquefaciens, PstI from Providencia 
stuartii, SmaI from Serratia marcescens, Sau3A from 
Staphylococcus aureus, AluI from Arthrobacter luteus, 
TagI from Thermus aquaticus and HpaII from Hae-
mophilus parainfluenza. 
A uniform nomenclature has been developed to simplify 
the naming of the restriction endonucleases (Smith and 
Nathans, 1973). The designation of these enzymes come 
from the source organism, using the first letter of the 
genus name plus the first 2 letters of the species, with 
additional letters/numbers to indicate the specific enzyme 
(since one species may produce several different res-
triction enzymes) (Dale, 2001). 
12) T4 DNA Ligase: This enzyme catalyses the formation 
of a phosphodiester bond between 3I-OH and 5I- phos-
phate ends in DNA using DNA molecules with cohesive 
ends as substrate (Daini, 2000). 
13) Exonuclease III: This enzyme is used for generating 
linear template DNA for the dideoxysequencing technique 
and generating staggered ends on dsDNA due to its 3I ---
- 5I exonuclease activity. 
14)  Exonuclease: This enzyme recognizes the terminal 
5I-phosphate of  dsDNA for its exonuclease activity. Its 
primary use is the removal of protruding 5I terminus from 
dsDNA which is needed for the terminal transferase 
tailing of DNA (Daini, 2000). 
15) SI Endonuclease: This enzyme is isolated from 
Aspergilus cryzae and it acts exclusively on ssDNA or 
RNA. It can break supercoiled DNA because it contains 
ss bubbles. It can also be used to distinguish supercoiled 
from both non-supercoiled, covalent circles and nicked 
circular DNA, both of which are resistant to the enzyme. 
16) Ligase: It seals single-stranded gaps (nicks) in 
double-stranded DNA. It is also used for the formation of 
recombinant DNA molecules in gene cloning.  
17) Polynucleotide kinase: It transfers a phosphate group 
from ATP to the 5I OH end of DNA or RNA. 
18) Primase: This is a special RNA polymerase, which 
makes a short primer required for DNA synthesis. 
19) Replicase: This is RNA-directed RNA polymerase 
used in replication of some RNA viruses. 
20) Reverse transcriptase: This is RNA-directed DNA 
polymerase. It synthesizes DNA (complementary DNA) 
using mRNA template. 
21) Ribonuclease (RNase): This enzyme degrades RNA 
molecules. 
22) RNA Polymerase: This enzyme synthesizes RNA, 
using a DNA template. 
23) RNase H: This is a specific RNAse which cuts RNA---






24) S1 nuclease: This enzyme degrades single-stranded 
DNA. 
25) Terminal transferase: This adds nucleotides to the 3I 
end of DNA, without requiring a template strand. 
26) Topoisomerase: This is a class of enzymes that alters 
the conformation of DNA, for example by changing the 
degree of winding or supercoiling. 




Enzymes as markers for disease  
 
Some enzymes are found only in specific tissues or in a 
limited number of such tissues. For example, lactase 
dehydrogenase (LDH) has 2 different forms, called 
isozymes, in heart and skeletal muscle (Campbell, 1999). 
The 2 forms differ slightly in amino acid composition and 
can be separated on the basis of charge as a result. 
Since LDH is a tetramer of four subunits, it too can exist 
in 5 different forms depending on the source of the 
subunits. An increase of any form of LDH in the blood 
indicates some kind of tissue damage. A heart attack can 
usually be diagnosed with certainty if there is an increase 
of LDH from heart. Also, there are different forms of 
creatine kinase (CK), an enzyme that occurs in the brain, 
heart and skeletal muscle. Appearance of the brain type 
can indicate a stroke or a brain tumour, whereas the 
heart type indicates a heart attack. After a heart attack, 
CK shows up more rapidly in the blood than LDH. Moni-
toring the presence of both enzymes extends the possi-
bility of diagnosis, which is useful, since a very mild heart 
attack might be difficult to diagnose. An elevated level of 
the isozyme from heart in blood is a definite indication of 
damage to the heart tissue (Campbell, 1999).  
Another useful enzyme assayed is acetyl 
cholinesterase (AChE), which is important in controlling 
certain nerve impulses. Many pesticides affect this 
enzyme, so farm workers are often tested to be sure that 
they have not received inappropriate exposure to these 
important agricultural toxins (Campbell, 1999). There are 
several enzymes that are typically used in the clinical 
laboratory to diagnose diseases. There are highly specific 
markers for enzymes active in the pancrease, red blood 
cells, liver, heart, brain, prostate gland and many of the 
endocrine glands. Since these enzymes are relatively 
easy to assay using automated techniques, they are part 
of the standard blood test veterinary and medical doctors 
are likely to need in the diagnosis and treatment/ 
management of diseases.  
 
 
Enzymes utilized in clinical diagnoses of diseases 
 
Many enzymes are involved in the clinical diagnoses of 
various diseases in human and veterinary medicine. 





these diseases. These enzymes could be classified into 
many classes. They are: 
 
1) Alkaline Phosphatase (ALP; EC 3.1.3.1): Alkaline 
phosphatases were the earliest serum enzymes to be 
recognized to have clinical significance, when in the 
1920s, it was discovered that they increase in bone and 
liver diseases (Kaneko, 1989). Since then, they have 
been the subject of more publications than any other 
enzyme (Stigbrand et al., 1984). Alkaline phosphates are 
a group of isoforms which hydrolyse many types of phos-
phate esters, whose natural substrate or substrates are 
unknown. The term ‘‘alkaline’’ refers to the optimal 
alkaline pH of this class of phosphatases in vitro.  
   In both humans and animals, the major sources of 
ALPs are the liver, bone, kidney and placenta. In hu-
mans, it is involved in bone and hepatobiliary diseases. 
ALPs are also of diagnostic importance in animal 
diseases. Total serum ALP activity has diagnostic value 
in the hepatic and bone diseases in dogs and cats 
(Kaneko, 1989). It is of little value in hepatic diseases of 
horses and ruminants because of the broad range of 
reference values against which the patients’ values must 
be compared. The range of serum ALP value in goats 
may be 10-fold with no evidence of hepatic damage. 
Values within the individual are fairly constant for 
sequential evaluation (Kaneko, 1989). 
2) Creatine Kinase (CK; EC 2.7.3.2): Creatine kinase 
isozymes are the most organ-specific serum enzymes in 
clinical use (Kaneko, 1989). They catalyse the reversible 
phosphorylation of creatine by ATP to form creatine 
phosphate, the major storage form of high-energy phos-
phate required by muscle. Creatine kinases are found in 
many parts of the body like the heart, brain, skeletal 
muscle and smooth muscle (Nduka, 1999), but they have 
their highest specific activity in the skeletal muscle 
(Kaneko, 1989). In humans, CK is associated with 
myocardial infarction and muscle diseases (Nduka, 
1999). Increase in CK in cerebrospinal fluid have been 
associated with a number of disorders in dogs, cats, 
cattle and horses (Mayhew et al., 1977; Wilson, 1977). 
The CKs are such sensitive indicators of muscle damage 
that, generally, only large increases in serum activity are 
of clinical significance (Lewis, 1978). 
3) Alanine Aminotransferase (ALT; EC 2.6.1.2): It was 
formerly known as glutamic puruvate transaminase; 
GPT). It catalyses the reversible transamination of L-
alanine and 2-oxoglutarate to pyruvate and glutamate in 
the cytoplasm of the cell. ALT can be found in the liver, 
skeletal muscle and heart (Nduka, 1999). The greatest 
specific activity of ALT in primates, dogs, cats, rabbits 
and rats is in the liver. It is a well established, sensitive 
liver-specific indicator of damage. However, ALT in the 
tissues of pigs, horses, cattle, sheep or goats is too low 
to be of diagnostic value (Boyd, 1983). It is used as an 
indicator of hepatopathy in toxicological studies which 
use small laboratory rodents  as  well  as  dogs  (Kaneko,  





4) Aspartate Aminotransferase (AST; EC 2.6.1.1): It was 
formerly called glutamic oxaloacetic transaminase; GOT). 
It catalyses the transamination of L-aspartate and 2-oxo-
glutarate to oxaloacetate and glutamate. AST is found in 
skeletal muscle, heart, liver, kidney and erythrocytes and 
is associated with myocardial, hepatic parenchymal and 
muscle diseases in humans and animals. The pre-sence 
of AST in so many tissues make their serum level a good 
marker of soft tissue but precludes its use as an organ-
specific enzyme (Boyd, 1983). Red blood cells contain a 
large amount of AST which leaks into plasma before 
haemolysis is seen (Kaneko, 1989).  
5) Sorbitol Dehydrogenase (SDH; EC 1.1.1.14): It is also 
called L-iditol dehydrogenase; IDH. It catalyses the rever-
sible oxidation of D-sorbitol to D-fructose with the 
cofactor NAD (Gerlich, 1983; Lessing and McGuiness, 
1982). The plasma activity is low in dog and horse 
plasma but appreciably greater in cattle, sheep, and goat 
serum. Aside from the testes, it is found in appreciable 
amounts only in hepatocytes (Boyd, 1983). As a result of 
this, an increase in plasma SDH is consistent with 
hepatocyte damage. SDH is liver specific in humans 
(Nduka, 1999) and all species of animals (Kaneko, 1989) 
and hepatic injury appears to be the only source of 
increased SDH activity. Although SDH is liver specific in 
all species, the already established usage of ALT in dogs 
and cats has limited SDH as a diagnostic indicator of 
hepatocellular damage to horses, cattle, sheep and goats 
(Kaneko, 1989). 
6) Lactate Dehydrogenases (LDH; EC 1.1.1.27): It 
catalyses the reversible oxidation of pyruvate to L(+) 
lactate with the cofactor NAD. The equilibrium favours 
lactate formation, but the preferred assay method is in 
the direction of pyruvate because pyruvate has an 
inhibitory effect on LDH. Lactate dehydrogenase has 
isoenzymes. LDH can be found in the heart, liver, 
erythrocyte, skeletal muscle, platelets and lymph nodes. 
In humans, it is involved in myocardial infarction, 
haemolysis and liver disease (Nduka, 1999). LDH 
isoenzyme profiles were the first isoenzyme profiles used 
in clinical veterinary medicine in an attempt to detect 
specific organ damage (Kaneko, 1989). The introduction 
of more highly organ-specific procedures has resulted in 
LDH no longer being in common use in veterinary 
medicine (Moore and Feldman, 1974).      
7) Cholinesterase (ChE): Serum cholinesterase (ChE) 
activity is composed of two distinct cholinesterases. The 
major substrate is acetylcholine, the neurotransmitter 
found at the myoneural junction. Acetylcholinesterase 
(AChE; EC 3.1.1.7) found at the myoneural junction is the 
true ChE and is essential in hydrolyzing acetylcholine so 
that the junction can be reestablished and prepared for 
additional signals (Whittaker, 1983). The myoneural junc-
tion AChE is also found in red blood cells (RBC), mouse, 
pig, brain and rat liver. Only a small amount of AChE is 
found in plasma. The ChE of plasma is a  pseudocholine- 




sterase, butylcholinesterase (ButChE; EC 3.1.1.8), which 
hydrolyses butyrylcholine four times faster than acetyl-
choline and is also located in white matter of the brain, 
liver, pancrease and intestinal mucosa (Kaneko, 1989). 
Decreases in ButChE have been reported in humans with 
acute infection, muscular dystrophy, chronic renal 
disease and pregnancy, as well as insecticide intoxifi-
cation. 
8) Lipase (Lip): Serum pancreatic lipases (EC 3.1.1.3; 
triacylglycerol lipase) catalyse the hydrolysis of trigly-
cerides preferentially at the 1 and 3 positions, releasing 
two fatty acids and a 2’- monoglyceride. Lipase can be 
found in the pancrease and hepatobiliary tract and is 
involved in pancreatitis and hepatobiliary disease (Nduka, 
1999).  
9) -Amylase (AMY; E.C. 3.2.1.1): -amylases are 
calcium-dependent metalloenzymes that randomly 
catalyze the hydrolysis of complex carbohydrates, e.g. 
glycogen at the 1-4 linkages. The products of this action 
are maltose and limit dextrins. The enzyme is a Ca2+ 
metalloenzyme which requires one of a number of 
activator ions such asCl- or Br- (Wahlefeld, 1983). Amy-
lase can be found in the salivary glands, pancrease and 
ovaries and is used as a diagnostic aid for pancreatitis. 
10) -Glutamyltransferase (GGT; 2.3.2.2): This is a 
carboxypeptidase which cleaves C-terminal glutamyl 
groups and transfers them to peptides and other suitable 
acceptors. It is speculated that GGT is associated with 
glutathione metabolism (Kaneko, 1989). The major sour-
ces are the liver and kidney and is involved in hepa-
tobiliary disease and alcoholism. Cholestatic disorders of 
all species examined result in increased serum GGT 
activity (Braun et al., 1987). 
11) Trypsin (EC; 3.4.21.4): Trypsins are serum proteases 
which hydrolyse the peptide bonds formed by lysine or 
arginine with other amino acids. They are secreted by the 
pancreas as the zymogen trypsinogen, which is conver-
ted to trypsin by intestinal enterokinase or trypsin itself. 
Trypsin can be found in the pancrease and is involved in 
pancreatitis, biliary tract and fibrocystic diseases. In 
humans, serum trypsin-like immunoreactivity (TLI) in-
creases in conditions which also result in increases in 
serum amylase, including renal failure (Kaneko, 1989). 
Serum TLI decreases in canine exocrine pancreatic 
insufficiency (Williams and Batt, 1983, 1988).     
12) Glutathione Peroxidases (GPx; EC 1.11.1.9): These 
are metalloenzymes containing four atoms of selenium 
per molecule of enzyme. They catalyze the oxidation of 
reduced glutathione by peroxide to form water and oxi-
dized glutathione (Kaneko, 1989). Because of the high 
concentration of selenium in glutathione peroxidases, 
there is a good direct correlation between the amount of 
red blood cell GPx activity and the selenium concen-
tration of other organs (Anderson et al., 1976; 
Ammerman et al., 1980). 
Other enzymes with disease diagnosis applications are 





cytes and is used in diagnosis of prostate carcinoma. 
Aldolase (ALD), found in skeletal muscle and heart and 
involved in muscle disease. Glutamate dehydrogenase 
(GLDH), found in the liver is used to diagnose hepatic 
parenchymal disease. Hydroxybutyrate dehydrogenase 
(HBD), which is the heart form of lactate dehydrogenase 
is involved in myocardial infarction.  
Just as enzyme assay is used to diagnose diseases in 
humans and animals, it may also be applied to the inve-
stigation of diseases in plants. For example, it has been 
found that an injury (either mechanical or pathogenic) 
results in a marked, localized increase in the activity of 
glucose-6-phosphate dehydrogenase, but not of glucose 
phosphate isomerase, indicating diversion of glucose 




Enzymes as antioxidants 
 
Various radicals can contribute to lipid oxidation in biolo-
gical systems (Hundson, 1990). Superoxide radicals O2
-, 
which may be produced by the enzyme xanthine oxidase 
and hydrogen peroxide (Kellogg and Fridovich, 1975) 
may be removed by the enzyme superoxide dismutase 
according to (Endo et al., 1985).  
 
                    Superoxide  
2O2
- + 2H+                        H2O2 + 3O2 (Endo et al., 1985).   
                     Dismutase 
 
The enzyme catalase may also play an important role in 
converting hydrogen peroxide to water and oxygen 
(Foote and Denny, 1968). 
 
            Catalase 
2H2O2                               2H2O + 3O2 (Foote and Denny, 1968).  
 
Since milk contains xanthine oxidase and superoxide 
dismutase, Korycka-Dahl and Richardson, (1980) con-




Enzymes used in immunoassays 
 
Enzymes may also be used as an alternative to radio-
isotopes as markers in immunoassays (Palmer, 2001). 
Such procedures, known as enzyme-immunoassays, 
have been used for the determination of a variety of 
proteins and hormones. The role of enzymes in immuno-
assay procedures is a secondary role, they are used to 
replace radioisotopes as markers, since they are not 
hazardous to health and can be detected by techniques 
which are more generally available. Any enzyme with a 





for this purpose. Two common examples of enzyme- 
immunoassay (EIA) procedures are enzyme-linked 
immunosorbent assay (ELISA) and enzyme-multiplied 
immunoassay test (EMIT). ELISA is a highly sensitive 
assay that can be used to detect either antigen or 
antibody (Engvall and Carlson, 1976).  
Applications of ELISA include diagnostics for 
noninfectious diseases involving hormones, drugs, serum 
components, oncofetal proteins, or autoimmune disea-
ses, as well as diagnostics for infectious diseases caused 
by bacterial, viral, mycotic or parasitic organisms (Voller 
et al., 1979). The enzymes frequently used in ELISA are 
Horseradish peroxidase, alkaline phosphatase and ß-
galactosidase. In EMIT, the activity of malate dehydro-
genase is assayed by standard enzyme methodology for 




Enzymes as therapeutic agents 
 
In a few cases enzymes have been used as drugs in the 
therapy of specific medical problems (Devlin, 1986). 
Streptokinase is an enzyme mixture prepared from 
streptococcus. It is usefull in clearing blood clots that 
occur in the lower extremities. Streptokinase activates the 
fibrinolytic proenzyme plasminogen that is normally 
present in plasma. The activated enzyme is plasmin. 
Plasmin is a serine protease like trypsin that attacks 
fibrin, cleaving it into several soluble components (Devlin, 
1986).  
Another enzyme of therapeutic importance is aspara-
ginase. Asparaginase therapy is used for some types of 
adult leukemia. Tumor cells have a nutritional require-
ment for asparagine and must scavenge it from the host’s 
plasma. By administering asparaginase i.v., the host’s 
plasma level of asparagine is markedly depressed, which 
results in depressing the viability of the tumor (Devlin, 
1986). Enzyme replacement in individuals that are 
genetically deficient in a particular enzyme are also 
applications of enzymes as therapeutic agents. Also, 
enzymes such as u-plasminogen activator, formerly 
known as urokinase, extracted from human urine, can be 
infused into the blood stream of patients at risk from a 
pulmonary embolism (a fragment of a blood-clot lodging 
in the pulmonary artery): these enzymes stimulate a 
cascade system responsible for the production of active 
plasmin, a proteolytic enzyme which digests fibrin, the 
main structural component of blood-clots. Some enzymes 
may also be used to restrict the growth of cancer cells by 
depriving them of essential nutrients: for example, L-
asaparaginase may be used in the treatment of several 
types of leukaemia, since the tumour cells, in contrast to 
normal cells, have a requirement for exogenous L-
asaparagine.    
Another example of therapeutic application of enzymes 
is the use of immobilized enzymes as components of arti- 




ficial kidney machines, which are used to remove urea 
and other waste products from the body, where kidney 
disease prevents this being done by natural processes 
(Palmer, 2001). Urea enters the machine from the blood, 
by dialysis (termed haemodialysis) and is converted to 
CO2 and NH4
+ by immobilized urease; toxic NH4
+ is then 
either trapped on ion exchange resins or incorporated 
into glutamate by the action of immobilized glutamate 
dehydrogenase linked to alcohol dehydrogenase to 
ensure coenzyme recycling, before the fluid is returned to 
the blood stream.  
 
 
Enzymes and Inborn errors of metabolism      
 
An inborn error of metabolism is characterized by the loss 
of activity of a specific enzyme as a result of a genetic 
mutation. Inborn errors are rare but possibly severe con-
ditions, often causing mental retardation or even death in 
infancy (Palmer, 2001). 
Enzymes are also used in the treatment of some inborn 
errors of metabolism. Ideally, complete treatment would 
be achieved if some normal enzyme could be introduced 
at the appropriate site. In the case of the enzymes of the 
gastrointestinal tract, this may easily be achieved by oral 
administration. For instance, where there is a lactase (ß-
galactosidase) deficiency in the cells of the intestine, 
which may occur as an inborn error or as a secondary 
feature of other diseases, ingested lactose (in milk) can-
not be broken down to galactose and glucose and severe 
discomfort results. This condition may be treated by 
removing milk products from the diet, or more conve-
niently by adding to it ß-galactosidase extracted from 
micro-organisms to perform the task normally done by 
the body’s lactase.    
Enzyme assays are used to confirm the diagnosis of 
inborn errors of metabolism. Examples are Tay-Sachs 
disease, caused by a deficiency of B-N-acetylhexo-
saminidase (also known as hexosaminidase A) activity. 
An example of an autosomal recessive inborn error of 
metabolism is phenylketonuria, where the patient has a 
severely limited ability to convert phenylalanine to 
tyrosine, because of a reduced activity of phenylalanine-
4-monooxygenase, better known as phenylalanine hydro-
xylase. An example of an inborn error which appears to 
be transmitted by an X-linked dominant mode is ornithine 
carbamoyl transferase (OCT) deficiency, also known as 
hyperammonaemia, a defect of urea cycle metabolism 
(Palmer, 2001). Another X-linked, but recessive, disease 
is the Lesch-Nyhan syndrome, a disorder of purine 
metabolism resulting from a deficiency of hypoxanthine 
phosphoribosyl transferase activity. 
 
 
Enzymes as sources of biofuels 
 
Frances Arnold is reported to  be  designing  better  enzy- 




mes used for making biofuels from cellulose (Goho, 
2008). Cellulolytic enzymes break down the cellulose 
found in biomass so that it can be used as a feedstock for 
biofuels. The increased use of cellulosic biofuels could 
cut green house-gas emissions and reduce reliance on 
soil. Sources of cellulosic biofuels are agricultural waste, 
wood chips and prairie grasses. Advantages of cellulosic 
biofuels over both gasoline and corn ethanol are (i). 
Burning cellulosic ethanol rather than glucose could cut 
greenhouse gas emissions by 87% and (ii). Cellulose is 
the most abundant organic material on earth. However, 
converting corn starch into sugar requires a single 
enzyme while breaking down cellulose involves a com-
plex array of enzymes called cellulases that work to-
gether (Goho, 2008). The general aim of the research 
work is that when fully exploited, cellulose ethanol will 
significantly reduse the use of gasoline.   
 
 
Enzymes in research  
 
Enzyme assay is used for research into processes as the 
browning of plant products, which prevents problems 
during the conversion of fruits and vegetables into drinks 
and preservatives. Enzymes are also important for re-
searches into diseases of humans and animals, bio-
technology research and other research areas, that is, 
enzymes have been used in research for better and alter-
native treatment of diseases. For example, Billigmann 
(1995) reported enzyme therapy as an alternative in 
treatments of herpes zoster. Bartsch (1974) reported the 
use of proteolytic enzymes in the treatment of herpes 
zoster. Scheef (1987) also reported the use of enzymes 
for therapeutic purposes. Pathney and Pachori (1986) 
reported a study of serum glycolytic enzymes and serum 
B hepatitis in relation to LIV.52 therapy. Also, (Stauder 
and Kabil, 1997; Kabil and Stauder, 1997) reported oral 
enzyme therapy in hepatitis C patients. Nikolaev et al. 
(1998) reported clinical use of Belosorb and Wobenzyme 
in the treatment of viral hepatitis B. Korpan et al. (1997) 
reported the mechanism of therapeutic efficacy of 
Wobenzyme in the treatment of toxic hepatitis. Jager 
(1990) reported hydrolytic enzymes in the treatment of 
HIV infections. Mikazans (1997) reported the possibility to 
treat Herpes Zoster using enzymes. Mudrak et al. (1997) 
reported adjuvant therapy with hydrolytic enzymes in 
recurrent laryngeal papillomatosis. The determination of 
enzyme activity is of importance in ascertaining the 
metabolic state of fruit tissues and their keeping quality on 
storage. For instance, the activity of lipoxygenase, pero-
xidase and acid phosphatase were enhanced in tomato 
fruits following treatments with Indole-acetic acid, Indole-
butyric acid and Naphthalene acetic acid (Olaiya, 2006). 
 
 
Enzymes as reagents in clinical chemistry  
 
Enzymes are used as reagents in clinical chemistry. D-





monly analysed by means of procedures involving 
glucose oxidase (Palmer, 2001). The reaction catalysed 
by glucose oxidase is utilized in a test-strip (Clinistix) for 
the screening of urine specimens. Glucose oxidase and 
the reagents for a colour-producing indicator reaction are 
impregnated into a plastic strip, so that the intensity of the 
blue colour obtained when it is dipped into a specimen 
gives an indication of the D-glucose content. This can be 
used in the diagnosis of diabetes mellitus. D-glucose may 
also be analysed by a hexokinase-catalysed reaction, 
although this enzyme can utilize any D-hexose as 
substrate, or by use of glucose dehydrogenase (Palmer, 
2001).  
Blood lactate and pyruvate are usually determined by 
means of lactate dehydrogenase-catalysed methods and 
blood urea is sometimes analysed by procedures invol-
ving urease (Palmer, 2001). Also, blood cholesterol may 
be determined by a reaction catalysed by cholesterol 
oxidase. Triglycerides and urate may also be analysed by 
enzymatic methods. 
Luciferase is a Mg2+- activated enzyme. Luciferase-
catalysed procedures are used for the analysis of 
adenosine triphosphate (ATP) (e.g. from blood platelets) 
and may also be used to determine the Mg2+ concen-
tration or the pO2.   
 
 
Enzymes as analytical reagents  
 
Enzymes display several characteristics which makes 
them suitable for analytical applications. Enzyme cataly-
ses a reaction which is both substrate-specific and 
product-specific. As a result of this, enzymes are very 
valuable as analytical reagents. They can be used for the 
estimation of specific substances, possibly present at 
very low concentrations, in the presence of other, chemi-
cally similar, substances (Palmer, 2001). Enzyme-based 
analytical methods are both specific and sensitive, which 
means little or no sample preparation is required in many 
cases. 
Another characteristic of enzyme-catalysed reactions 
which makes them suitable for analytical applications is 
that they proceed under relatively mild conditions (e.g. at 
near neutral pH and around room temperature). As a 
result of this, they are simple to set up and can be used 
for the analysis of substances which would be unstable 
under more extreme conditions. Enzyme-based analytical 
procedures may be designed to determine the concen-
tration of substrates, coenzymes, activators and inhibitors 
(Palmer, 2001). However, all solutions used in enzymatic 
analysis procedures must be free from contamination by 
micro-organisms and metal ions. 
 
 
Enzymes with industrial applications 
 
Enzymes have wide applications in different industries 





The activity of certain enzymes may be determined 
before and after pasteurization and sterilization proce-
dures to acertain whether these have been properly 
done. For example, alkaline phosphatase and invertase 
present in milk are inactivated within the same tempe-
rature range as is required for pasteurization. The active-
ties of these two enzymes at the end of the whole 
process could give an indication of its effectiveness. 
The degree of bacterial contamination of foodstuffs can 
be estimated by the assay of microbial enzymes not 
normally present in food. This principle is applied in the 
assay of milk to determine whether its been contami-
nated. Milk should normally contain only small amounts 
of reductases, but bacteria produces large amounts. 
Reductases may be easily assayed because they 
catalyse the reduction of methylene blue to colourless 
leuco-methylene blue under anaerobic conditions 
(Palmer, 2001). A test-strip (Bactostrip) incorporating 2,3, 
4-triphenyltetrazolium salts provide a convenient way of 
testing for thr presence of bacteria, a red formazan dye 
being produced as a result of the action of reductase. 
Enzymes are also used to determine whether stored 
plant products are suitable for use as foodstuffs. For 
example, -amylase should be present in relatively low 
amounts in stored wheat seeds. Hence, the -amylase 
activity of food plants may be determined to ascertain the 
degree of their suitability for use for the desired purpose. 
The freshness of meat may be determined by the use of 
monoamine oxidase to detect amines formed during 
degradation. Also, enzyme-immunoassay is used to de-
tect food adulteration, e.g. the addition of horse to beef 
products (Palmer, 2001).   
The concentrations of various sugars and individual 
amino acids in foodstuffs may also be determined by 
specific methods of enzymatic analysis. In winemaking, 
the concentration of malic acid is sometimes determined 
by a method involving malate dehydrogenase. The clarifi-
cation of cider, wines and fruit juices (e.g. apple) is 
usually achieved by treatment with fungal pectinases 
(Palmer, 2001). Papain is sometimes used as a meat 
tenderizer. Papain (and other proteases) may also be 
used in the brewing industry to prevent chill hazes, 
caused by precipitation of complexes of protein and 
tannin at low temperatures. Bacterial -amylase (from 
Bacillus subtilis) which is even more heat stable than 
wheat -amylase, is of importance in the brewing 
industry. The traditional use of yeasts (e.g. Saccharo-
myces carlsbergensis) in the baking and brewing 
industries arose because they contain the enzymes for 
alcoholic fermentation, alcohol dehydrogenase (Palmer, 
2001). Invert sugar, a mixture of glucose and fructose, is 
produced from sucrose by the action of yeast ß-fructo-
furanosidase, better known as invertase (an enzyme 
which can be extracted by disruption of the yeast cell 
wall). Enzymes are also of great value in the pharma-
ceutical industry. For example, they are used for the 
conversion   of   naturally  occurring  penicillin  G  (benzyl  




penicillin) to 6-amino penicillanic acid (6-APA). This reac-
tion is catalysed by penicillin amidase (Palmer, 2001). 
Bacterial proteases are also used in the leather and 
textile industries to loosen hair (or wool) and enable it to 
be seperated from hide. Enzymes are also used in the 
production of biological molecules (Daini, 2000). 
Enzymes were used in a variety of ways long before 
they were recognized as definite biochemical compo-
nents in living cells. Processes for making bread, wine, 
cheese, vinegar, alcohol etc have been known from anti-
quity (Aurand et al., 1987).  
Enzymes have several characteristics that make them 
significant for use in industrial processes. They are:  
 
1. They accomplish and accelerate a reaction efficiently. 
2. The rates of the reaction can be readily controlled by 
adjusting the temperature, pH and reaction time. 
3. Enzyme activity may be destroyed by heating to dena-
turing temperatures. 
4. They are natural in origin and non-toxic and therefore 
may remain in the product without any harmful cones-
quences. 
5. They exhibit great specificity and can be used gene-
rally at levels of less than 1% of the commercial product 
batch (Aurand et al., 1987). 
 
 
Enzymes and immune system 
 
Enzymes become part of the immune system (Alpha-2-
macroglobulin), working with it and facilitating its function. 
(Laver et al., 2001) reported the modulation of growth 
factor binding properties of alpha 2-macroglobulin by 
enzyme therapy. Ingestion of proteinases was found to 
trigger the formation of intermediate forms of alpha-2-
macroglobulin displaying high affinity of transforming 
growth factor- beta (TGF-ß). They observed maximum 
binding of TGF- ß 1 - 2 h after bolus ingestion and stea-
dily leveled off with time. They concluded that intestinal 
absorption of proteinases triggers the formation of TGF- 
ß binding species of alpha 2 macroglobulin in blood. 
Mediated by this process high concentrations of TGF- ß 
might be reduced via enhanced clearance of alpha 2-
macroglobulin TGF- ß complexes. Thus, proteinase 
therapy may have beneficial effects in treatment of 
fibrosis and certain cancers accompanied by excessively 
high TGF- ß concentrations. Desser et al. (2001) reported 
that oral therapy with proteolytic enzymes decreases 
excessive TGF-beta levels in human blood. In the study, 
they stated that therapy with oral proteolytic enzymes 
(OET) with combination drug products containing papain, 
bromelain, trypsin and chymotrypsin have been shown to 
be beneficial in clinical settings such as radiotherapy-
induced fibrosis, bleomycin pneumotoxicity and immuno-
suppression in cancer, all of which are nowadays 
knowned to be accompanied by excessive transforming 
growth factor - beta (TGF- ß ) production.They concluded  




that their results support the concept that OET is bene-
ficial in diseases characterized in part by TGF- ß1 
overproduction.        
 
 
Animal-derived enzymes  
 
Enzymes derived from animals e.g. rennet, bovine liver 
catalase, animal lipase, pancreatin, pepsin, trypsin and 
lysozyme that are not genetically engineered may be 
used in processed foods labeled as ‘‘organic’’. Incidental 
additives, including processing aids used in the produc-
tion of enzyme preparations, must be non-synthetic or be 
substances that appear on the National list of ingredients 
allowed for use in foods labelled ‘‘organic’’ (consensus). 
Animal-derived rennet and bovine rennet are direct food 
substances affirmed as Generally Recognized As Safe 
(GRAS) (FDA, 1995). Rennet and bovine rennet are 
commercial extracts containing the active enzyme rennin, 
also known as chymosin. Rennet is the aqueous extract 
prepared from cleaned, frozen, salted or dried fourth 
stomachs of calves, kids or lambs. Bovine rennet is the 
product from adults of the animals listed above. Both 
products are called rennet. Rennin is the milk coagulating 
enzyme of the mucosa of the fourth ‘‘true’’ stomach 
(abomasum) of young calves. The structure of rennin 
consists of a single polypeptide with an internal disulfide 
bridge (Budaveri, 1996). Animals used for the production 
of rennet and bovine rennet must certified free of bovine 
spongiform encephalopathy (BSE) (cattle) or scrapie 
(sheep, goats). Rennet is a coagulant used to curdle milk 
to be made into cheese or sour cream. The milk-clotting 
effect of rennin is due to a specific and limited hydrolysis 
of the E-casein surrounding the protein micelles in milk. 
As a result, the micelles lose their electrostatic charge 
and are able to aggregate with the help of calcium and 
phosphorus ions to form a network that traps the fat 
micelles and a gel structure is thus formed (Nelsen, 
1992).         
 
 
Plant and fungi-derived enzymes 
 
There are many different plant and fungal enzymes used 
in processing. Among them is pectinase, poly (1,4--D-
galacturonide) glycanohydrolase, poly (1,4--galacturo-
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